A newer approach to improve diagnosis and treatment of Alzheimer’s disease involves what is called “precision medicine.” This means taking into consideration a patient’s genes, environment, and lifestyle in order to customize treatment. Dr. Howard Fillitt suggests that research on biomarker blood tests and monoclonal antibody drugs can help primary care physicians to better understand… Continue reading →